BRN brainchip holdings ltd

0.00%

20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-191

First 191 Last

Share
Profile

Follow
prosperity

9,675 Posts.

954

28/02/25

15:10

Post #: 78078265
Share

Originally posted by belkin: ↑

I believe that commercial progress has been hampered by being on the ASX an that this single point is the reason we have not seen more commercial success.

I think I posted yesterday a hypothetical conversation taking place at the contract signing table which I will repeat to refresh.

You can imagine the customer saying, we're ready to sign and our company going great, heres a press release/asx announcement we want your input on and agreement on to which the customer goes, What? What do you mean you want to tell the world who we are? We can't agree to that. See ya. When you get around this hurdle let me know and we will re evaluate.

The hurdle is the ASX disclosure guidelines/rules.

Your points througout your post resonate though and need to be addressed by the board. I can't imagine a scenario whereby they don't address these concerns and more.

Expand

2022 was meant to the big year
2023 was then meant to be the transformation year
2024 was virtually guaranteed by Sean
2025 is ready for delisting after a mountain of dilution.
2026 might be the nail in the coffin.

BRN Price at posting: 20.5¢ Sentiment: Sell Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 191 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 20.0¢		Change 0.000(0.00%)		Mkt cap ! $405.0M

Open	High	Low	Value	Volume
20.5¢	21.0¢	20.0¢	$1.544M	7.615M

Buyers (Bids)

No.	Vol.	Price($)
3	61852	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	217258	9

View Market Depth

No.	Vol.	Price($)
2	32537	0.200
25	968327	0.195
38	1574473	0.190
40	1943108	0.185
65	1281316	0.180

Price($)	Vol.	No.
0.205	179258	6
0.210	1653584	26
0.215	846002	16
0.220	1267378	34
0.225	840448	18

Last trade - 16.20pm 27/06/2025 (20 minute delay)

BRN (ASX) Chart

Ann: BrainChip Evaluates Redomiciling to US, page-191

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BrainChip Evaluates Redomiciling to US, page-191

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News